Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 12 04:00PM ET
52.46
Dollar change
-0.27
Percentage change
-0.51
%
IndexRUT P/E- EPS (ttm)-0.93 Insider Own7.05% Shs Outstand110.27M Perf Week-10.90%
Market Cap5.78B Forward P/E- EPS next Y-1.55 Insider Trans-9.88% Shs Float102.50M Perf Month-27.49%
Income-93.72M PEG- EPS next Q-0.27 Inst Own72.77% Short Float12.01% Perf Quarter-27.10%
Sales0.00M P/S- EPS this Y-22.88% Inst Trans-0.29% Short Ratio3.37 Perf Half Y200.63%
Book/sh8.47 P/B6.19 EPS next Y-38.44% ROA-16.76% Short Interest12.31M Perf Year121.02%
Cash/sh8.73 P/C6.01 EPS next 5Y40.00% ROE-17.55% 52W Range8.28 - 99.41 Perf YTD181.89%
Dividend Est.- P/FCF- EPS past 5Y-18.89% ROI-10.03% 52W High-47.23% Beta1.03
Dividend TTM- Quick Ratio29.48 Sales past 5Y0.00% Gross Margin- 52W Low533.57% ATR (14)4.35
Dividend Ex-Date- Current Ratio29.48 EPS Y/Y TTM0.82% Oper. Margin0.00% RSI (14)31.79 Volatility6.07% 6.97%
Employees27 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price112.62
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-6.06% Payout- Rel Volume0.78 Prev Close52.73
Sales Surprise- EPS Surprise6.04% Sales Q/Q- EarningsApr 24 AMC Avg Volume3.66M Price52.46
SMA20-16.49% SMA50-23.68% SMA20041.84% Trades Volume2,911,109 Change-0.51%
Date Action Analyst Rating Change Price Target Change
May-16-24Upgrade Raymond James Outperform → Strong Buy $115 → $116
Mar-26-24Reiterated Oppenheimer Outperform $116 → $138
Mar-07-24Initiated Jefferies Buy $110
Feb-28-24Reiterated Oppenheimer Outperform $46 → $116
May-31-23Resumed ROTH MKM Buy $32
Mar-28-23Reiterated Maxim Group Buy $15 → $25
Mar-17-23Initiated Stifel Buy $22
Jul-29-21Resumed BTIG Research Buy $20
May-25-21Downgrade Raymond James Strong Buy → Outperform $27 → $12
Jun-05-20Initiated BMO Capital Markets Outperform $14
Jun-12-24 10:00AM
Jun-11-24 06:52AM
Jun-10-24 09:45AM
Jun-09-24 08:45AM
Jun-08-24 07:40AM
05:45PM Loading…
Jun-07-24 05:45PM
02:52AM
Jun-06-24 05:23PM
07:45AM
Jun-05-24 10:28AM
09:42AM
Jun-04-24 04:17PM
01:36PM
08:00AM
07:46AM
07:05AM Loading…
07:05AM
06:00AM
Jun-03-24 10:15AM
09:00AM
May-31-24 05:45PM
06:00AM
06:00AM
05:33AM
May-30-24 04:03PM
May-29-24 06:30AM
May-28-24 09:30AM
May-27-24 06:58PM
06:13PM
May-26-24 08:31AM
May-25-24 12:00PM
08:15AM Loading…
08:15AM
May-24-24 06:30AM
May-23-24 06:00AM
May-22-24 08:15AM
07:07AM
May-21-24 02:36PM
May-20-24 07:02AM
May-18-24 06:47AM
May-17-24 03:02PM
09:00AM
07:30AM
06:15AM
May-16-24 07:00AM
May-15-24 11:36AM
May-14-24 07:08AM
May-13-24 10:00AM
08:15AM
May-10-24 06:55AM
May-09-24 10:34AM
May-08-24 01:22PM
May-07-24 02:04PM
May-06-24 03:10AM
May-03-24 03:05AM
May-02-24 06:49PM
May-01-24 11:59AM
Apr-28-24 10:30AM
09:07AM
Apr-26-24 08:15AM
06:00AM
Apr-25-24 11:28AM
10:30AM
09:01AM
07:37AM
03:20AM
Apr-24-24 08:57PM
05:37PM
05:32PM
04:05PM
05:50AM
Apr-23-24 09:15AM
Apr-22-24 06:00AM
Apr-19-24 05:45PM
11:16AM
Apr-17-24 04:05PM
Apr-16-24 01:19PM
Apr-13-24 08:47AM
Apr-12-24 06:25AM
Apr-11-24 01:49PM
12:24PM
Apr-10-24 05:45PM
08:59AM
Apr-09-24 10:00AM
06:45AM
Apr-08-24 05:55AM
Apr-06-24 08:47PM
07:45AM
Apr-05-24 07:15AM
Apr-04-24 09:15AM
06:30AM
05:50AM
04:55AM
Apr-02-24 05:50AM
Apr-01-24 01:49PM
Mar-31-24 10:15PM
09:31AM
06:15AM
Mar-29-24 09:15AM
09:00AM
08:51AM
Mar-28-24 01:50PM
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZANTE GREGChief Financial OfficerMay 03 '24Option Exercise4.8634,249166,285241,610May 03 08:51 PM
ZANTE GREGChief Financial OfficerMay 03 '24Sale74.6966,7564,986,008174,854May 03 08:51 PM
Mancini MariannaChief Operating OfficerMay 01 '24Option Exercise6.18281,4251,740,575629,933May 02 09:27 PM
Mancini MariannaChief Operating OfficerMay 01 '24Sale78.66281,42522,136,474348,508May 02 09:27 PM
Lian BrianPresident & CEOFeb 09 '24Sale29.9045,0001,345,5002,139,882Feb 09 08:59 PM
Lian BrianPresident & CEOFeb 08 '24Option Exercise3.76189,079711,3672,404,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Option Exercise8.3225,000208,00025,000Feb 08 07:38 PM
Lian BrianPresident & CEOFeb 08 '24Sale26.87269,0797,230,7842,184,882Feb 08 07:40 PM
Rouan Sarah KathrynDirectorFeb 08 '24Sale28.0525,000701,2500Feb 08 07:38 PM
Lian BrianPresident & CEOJan 31 '24Option Exercise1.2385,000104,5502,349,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 31 '24Sale24.7185,0002,100,7502,264,882Jan 31 08:39 PM
Lian BrianPresident & CEOJan 30 '24Option Exercise1.2335,00043,0502,299,882Jan 30 09:05 PM
Lian BrianPresident & CEOJan 30 '24Sale23.9535,000838,2502,264,882Jan 30 09:05 PM
Rouan Sarah KathrynDirectorJan 19 '24Option Exercise8.3230,000249,60030,000Jan 19 08:35 PM
Rouan Sarah KathrynDirectorJan 19 '24Sale23.0530,000691,5000Jan 19 08:35 PM
ZANTE GREGChief Financial OfficerJan 04 '24Sale17.9015,000268,500180,730Jan 04 09:35 PM